Abstract

Beta-blockers are a subgroup of antiarrhythmic drugs that restore and stabilize heart rhythm, primarily by inhibiting beta-adrenergic receptors. Though grouped by their primary target, the beta-adrenergic receptors, beta-blockers vary in target specificity, side-effects, pharmacological and physico-chemical profiles. As many other drugs, beta blockers are amphiphiles and some regulate a range of membrane proteins at similar concentration, suggesting a common mechanism. It is in this context important that membrane proteins are hydrophobically coupled to their host lipid bilayer, meaning that their function may be regulated by changes in bilayer properties.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.